你即將離開本站

並前往https://clinicaltrials.gov/ct2/show/NCT03091192

Savolitinib vs. Sunitinib in MET-driven PRCC. - Full Text View

This study is designed for patients diagnosed with MET-driven, unresectable and locally advanced or metastatic Papillary Renal Cell Carcinoma.

確定！ 回上一頁

查詢 「Sunitinib」的人也找了：

  1. sunitinib機轉
    2.
  2. sunitinib健保
    3.
  3. sunitinib仿單
    4.
  4. sunitinib副作用
    5.
  5. sunitinib標靶
    6.
  6. Sunitinib
    7.
  7. 舒癌特療程
    8.
  8. Sorafenib
    9.